LeadScope

Details

DC Role: 
Project Partner

ABOUT THIS PROJECT

The ICH M7 guidance provides a specification for the use of in silico models for evaluating the genotoxicity of impurities in pharmaceuticals. The guidelines support the combined use of consensus models based on statistical-based (Q)SAR and expert rule-based computational toxicology combined with an expert opinion to support a regulatory submission. Leadscope and DC have established a partnership providing a market leading consulting service to execute the modelling and reporting requirements of such a regulatory submission. It is based on the regulatory-accepted Leadscope software developed in close collaboration with the US FDA.

 

Latest Tweets

Douglas Connect (1 week ago)
RT @eNanoMapper: Protégé 5.2.0 released https://t.co/TGg7V4e03v (our tutorial on how to use it for our ontology: https://t.co/Dv00XOzyyB)
Douglas Connect (1 week ago)
RT @barryhardy: Obtain introduction on YouTube to #OpenTox #Garuda #DataAnalysis #2017SOT #ToxExpo @SOToxicology @DouglasConn 2160 https://…
Douglas Connect (3 weeks ago)
Please note that the early-bird/bursary deadlines (31 March) for the #eChemInfo workshop are approaching quickly: https://t.co/NxBAmGIFtz
Douglas Connect (3 weeks ago)
RT @PLOSCompBiol: PathVisio 3: An Extendable Pathway Analysis Toolbox, from Kutmon et al. https://t.co/s4onP5KT2P #SoftwareWednesdays https…
Douglas Connect (3 weeks ago)
RT @ACEnanoH2020: Our website has been officially launched! Check https://t.co/aRNgkYS4GL to be up to date of ACEnano progress. Wish you li…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com